DETERMINATION OF IMIPENEM AND CILASTATIN SODIUM IN PRIMAXIN(R) BY FIRST-ORDER DERIVATIVE ULTRAVIOLET SPECTROPHOTOMETRY

被引:21
作者
FORSYTH, RJ
IP, DP
机构
[1] Pharmaceutical Research and Development Department, Merck Research Laboratories, West Point
关键词
PRIMAXIN(R); IMIPENEM; CILASTATIN SODIUM; DERIVATIVE UV SPECTROPHOTOMETRY;
D O I
10.1016/0731-7085(94)00067-0
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A UV-spectrophotometric assay to measure the concentrations of the active drug components (imipenem and cilastatin) or Primaxin(R) for routine release testing is described. The assay is based on the use of first order derivative spectrophotometry. The trough amplitudes in the first derivative spectrophotometric spectra at 243 and 318 nm were selected to determine cilastatin and imipenem, respectively. A linear relationship (R > 0.99) between the trough amplitudes and concentrations was demonstrated over the range 14-42 mu g ml(-1) for both drug components. Commercial IV formulations and laboratory prepared mixtures containing both drugs in different proportions were assayed using the developed method with good recoveries (ave. 100.6%). The method is rapid, precise, accurate and was shown to be equivalent to the more time consuming LC method; which is currently used for routine release testing. The specificity and stability indicating properties of the method will also be addressed.
引用
收藏
页码:1243 / 1248
页数:6
相关论文
共 11 条
[1]   PROPERTIES OF MM-13902 AND OTHER CARBAPENEM ANTIBIOTICS INVITRO AND INVIVO [J].
BASKER, MJ ;
BOON, RJ ;
BOX, SJ ;
PRESTIGE, EA ;
SMITH, GM ;
SPEAR, SR .
JOURNAL OF ANTIBIOTICS, 1983, 36 (04) :416-422
[2]   COMPATIBILITY OF IMIPENEM-CILASTATIN SODIUM WITH COMMONLY USED INTRAVENOUS SOLUTIONS [J].
BIGLEY, FP ;
FORSYTH, RJ ;
HENLEY, MW .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (11) :2803-2809
[3]   IMIPENEM IN BIOLOGICAL-FLUIDS ANALYZED BY DERIVATIVE UV-SPECTROPHOTOMETRY [J].
CARLUCCI, G ;
MAZZEO, P ;
BOLOGNA, M .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (10-12) :1169-1172
[4]  
FINLAY KR, 1983, INVEST OPHTH VIS SCI, V24, P1147
[5]  
KAHAN FM, 1983, J ANTIMICROB CHEMOTH, V12, P1
[6]   METABOLISM OF THIENAMYCIN AND RELATED CARBAPENEM ANTIBIOTICS BY THE RENAL DIPEPTIDASE, DEHYDROPEPTIDASE-I [J].
KROPP, H ;
SUNDELOF, JG ;
HAJDU, R ;
KAHAN, FM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (01) :62-70
[7]   PHARMACOKINETICS AND TOLERANCE OF N-FORMIMIDOYL THIENAMYCIN (MK0787) IN HUMANS [J].
NORRBY, SR ;
ALESTIG, K ;
FERBER, F ;
HUBER, JL ;
JONES, KH ;
KAHAN, FM ;
MEISINGER, MAP ;
ROGERS, JD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (02) :293-299
[8]  
NORRBY SR, 1982, 12TH CURR CHEM IMM P, V1, P743
[9]  
OBERHOLTZER ER, 1988, ANAL PROFILES DRUG S, V17, P73
[10]   STABILITY AND KINETICS OF DEGRADATION OF IMIPENEM IN AQUEOUS-SOLUTION [J].
SMITH, GB ;
DEZENY, GC ;
DOUGLAS, AW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (08) :732-740